This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Follow-up examination after treatment for malignant neoplasms
Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
4156 |
4. Check minimum number of eventsNone |
4156 |
5. Include endpointsNone |
4156 |
6. Filter based on genotype QC (FinnGen only) |
4030 |
Control definitions (FinnGen only)
Control exclude
Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z[0-1]
Similar endpoints
↥List of similar endpoints to
Follow-up examination after treatment for malignant neoplasms
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for examination and investigation
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4030 | 2281 | 1749 |
| Unadjusted period prevalence (%) | 0.89 | 0.90 | 0.88 |
| Median age at first event (years) | 65.59 | 61.86 | 70.45 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS – Follow-up examination after treatment for malignant neoplasms
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).